A recent study reveals that people who come off popular GLP-1 drugs like Mounjaro or Wegovy may regain reduced body mass at a significantly accelerated pace than those who halt traditional diet and exercise programs.
Findings released in a leading health publication demonstrates that while obese people frequently drop substantial amounts of their total mass while using the jabs, the weight returns at an estimated rate of 0.8 kg per month after stopping.
"Individuals buying such medications must be cognizant of the potential of quick rebound weight gain when the treatment concludes," cautioned researcher Dr. Susan Jebb.
That rate of recovery means a return to pre-treatment mass within about 18 months.
Analyzing Treatments
The analysis, which examined 37 of trials involving over 9,000 of patients, contrasted the results of the injectable medications with other pills.
Researchers emphasize that people who shed pounds through diet and exercise generally have a more gradual creep back—perhaps 100 grams monthly—post-intervention.
Explaining the Quick Regain
Experts propose the mode of action of the injections accounts for the heightened weight return.
The injections mimic a natural hormone called GLP-1, which controls appetite.
"Artificially providing the hormone levels several times higher than normal could lead to the system to generate a reduced amount of its endogenous GLP-1, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition expert.
"Withdrawal of this medication results in appetite is no longer kept in check, making overeating a significant risk."
An Ongoing Issue?
Medical guidelines recommend the injections for people with obesity-related medical conditions, accompanied by prescribed lifestyle changes.
A number of clinicians contend that, considering the likelihood of relapse, the therapy might need to be long-term.
This opinion is reinforced by pharmaceutical companies, who note that the findings "underscore the chronic character of excess weight," similar to managing conditions like hypertension.
User Experiences
Users who have stopped the medication describe a intense return of cravings.
"I experienced a switch flipping and you're instantly extremely hungry," said an individual.
This difficulty is worsened if individuals have not adopted permanent lifestyle or habit changes during therapy.
Growing Interest
Figures indicate that millions of adults in the UK have used weight-loss jabs in the last 12 months, with desire remaining high.
- Use is greater among women than males.
- The 40s and 50s demographic shows the greatest usage rates.
- A large proportion obtain the medications through private prescriptions rather than the NHS.
Finally, researchers stress that while GLP-1 drugs are effective tools for shedding pounds, they are not a standalone solution and lasting health benefits hinges on integrated lifestyle changes.
